LWM
GOSS icon

Liberty Wealth Management’s Gossamer Bio GOSS Stock Holding History

Liberty Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$25K – 541
2021
Q3 		$25K Hold
2,000
– – 0.01% 589
2021
Q2 		$16K Hold
2,000
– – 0.01% 555
2021
Q1 		$20K Hold
2,000
– – 0.01% 460
2020
Q4 		$20K Buy
+2,000
New +$19.7K 0.01% 457

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Liberty Wealth Management's GOSS Position: Q4 2021 in Review

Liberty Wealth Management sold out of Gossamer Bio (GOSS) in Q4 2021, closing a stake of 2,000 shares — an estimated $25K sold.

Liberty Wealth Management first reported a position in GOSS in Q4 2020 and held it in 4 quarters. The position peaked at $25K in Q3 2021. 133 funds tracked by Wall St. Rank hold GOSS as of Q4 2021.

  • Liberty Wealth Management reported no remaining Gossamer Bio position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 2,000 Gossamer Bio shares in Q4 2021, an estimated $25K.
  • Liberty Wealth Management first reported a position in Gossamer Bio in Q4 2020 and held it in 4 quarters.
  • Liberty Wealth Management's Gossamer Bio position peaked at $25K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.